Lingyun Liu
1 appearance in the program
Sessions & presentations
PS26: Challenges and Novel Approaches in Rare Disease Trials from Industry and Regulatory Perspectives
Presenting Author
Presentation: Dose Switching after Interim Dose Selection in Seamless Two-Stage Adaptive Designs for Drug Development in Rare Diseases
Parallel · Fri, Sep 26 , 8:30 AM